# Inomagen Therapeutics, Inc. — Form D

Inomagen Therapeutics, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2014-11-24. The offering totals $400K, of which $200K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2014-11-24
- Form: D
- Accession: 0001626370-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $400K
- Amount sold: $200K
- Remaining: $200K
- Minimum investment: $25K
- Investors: 8
- Date of first sale: 2014-11-12
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-228972

## Issuer

- Name: Inomagen Therapeutics, Inc.
- CIK: 0001626370
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 1375 W Fulton Street, CHICAGO, IL, 60607
- Phone: 312 805 8701

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Rishi Arora | Director | Chicago, IL |
| Rishi Arora | Executive Officer | Chicago, IL |
| Marc R Penn | Director | Chicago, IL |
| James R Vogler | Director | Chicago, IL |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-06-20](https://search.stillhousedata.com/formd/0001626370-25-000002) | D | $3.8M | $140K |
| [2024-04-12](https://search.stillhousedata.com/formd/0001626370-24-000003) | D | $6.6M | $200K |

## More

- [CIK 1626370 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1626370&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001626370-14-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.